Major Peripheral Blood Cell Counts 10 Days After 6 Gy TBI and IP TPO Administration
Time Relative to TBI . | TPO Dose (μg) . | n . | Red Blood Cells (×1012/L) . | White Blood Cells (×109/L) . | Platelets (×109/L) . |
---|---|---|---|---|---|
— | — | 14 | 7.2 ± 0.5 | 0.4 ± 0.1 | 144 ± 62 |
+24h | 0.3 | 15 | 7.5 ± 0.6 | 0.4 ± 0.1 | 465 ± 142* |
+2h | 0.3 | 15 | 9.0 ± 0.6*-151 | 1.1 ± 0.4*-151 | 739 ± 165*-151 |
−2h | 0.3 | 3 | 9.0 ± 0.2*-151 | 0.7 ± 0.2*-151 | 533 ± 55*-152 |
−2h | 30.0 | 3 | 9.0 ± 0.3*-151 | 0.8 ± 0.2*-151 | 718 ± 86*-151 |
Normal mice | — | 19 | 10.2 ± 0.6 | 5.3 ± 1.9 | 1,123 ± 89 |
Time Relative to TBI . | TPO Dose (μg) . | n . | Red Blood Cells (×1012/L) . | White Blood Cells (×109/L) . | Platelets (×109/L) . |
---|---|---|---|---|---|
— | — | 14 | 7.2 ± 0.5 | 0.4 ± 0.1 | 144 ± 62 |
+24h | 0.3 | 15 | 7.5 ± 0.6 | 0.4 ± 0.1 | 465 ± 142* |
+2h | 0.3 | 15 | 9.0 ± 0.6*-151 | 1.1 ± 0.4*-151 | 739 ± 165*-151 |
−2h | 0.3 | 3 | 9.0 ± 0.2*-151 | 0.7 ± 0.2*-151 | 533 ± 55*-152 |
−2h | 30.0 | 3 | 9.0 ± 0.3*-151 | 0.8 ± 0.2*-151 | 718 ± 86*-151 |
Normal mice | — | 19 | 10.2 ± 0.6 | 5.3 ± 1.9 | 1,123 ± 89 |